Venture capital firm based in London, UK
CyberSmart scores £12.8 million in Series B funding to supercharge its mission of 24/7 cyber protection for small businesses—are you ready to join the fight against digital threats? Read more
Edinburgh-based Carcinotech secures £4.2m funding to advance revolutionary 3D printed micro-tumour technology, revolutionizing drug screening and improving cancer treatment. Read more
Neupulse, a trailblazing spinout from the University of Nottingham, secures £500,000 to revolutionize Tourette’s syndrome treatment with an innovative wristband, pushing total funding to nearly £4.5 million and promising a game-changing non-drug therapy! Read more
Edinburgh's Chromacity is revolutionizing healthcare and agriculture with over £1 million in funding to launch groundbreaking laser technologies that promise to tackle pressing industry challenges! Read more
Healthtech | 57.1% |
Insurtech | 14.3% |
Cyber security | 14.3% |
Greentech | 14.3% |